ACS GCI Pharmaceutical Roundtable’s Medicinal Chemistry group is seeking to fund a one year R&D program targeting the identification and development of alternatives to the commonly employed stoichiometric hydride-based reagents or transition-metal catalyzed silane reductions, with a focus on substrates that are widely applicable to the pharmaceutical industry. Proposals are invited from public and private institutions of higher education worldwide. This collaborative project is intended for a student within the selected Principal Investigator’s research group. One grant in the amount of $50,000 will be awarded to support execution of research for a period of 1 year. Deadline for receipt of proposals is June 4th, 2014 at 5 PM EDT (GMT-4).